Based on our findings, it is likely that PnPP-19 is enhancing the normal outflow of aqueous humor and directly halting the advancement of optic nerve degeneration. As a result, this artificial peptide shows promise as a potential medication for treating glaucoma, either on its own or alongside traditional medications.